Table 2.
Predictor Variable | N | Unadjusted p-value* | Adjusted p-value** |
---|---|---|---|
HES subtype | 164 | 0.012 | p<.001 |
LDH | 146 | 0.038 | 0.156 |
Cardiac involvement | 164 | 0.058 | 0.156 |
Serum vitamin B12 | 151 | 0.083 | 0.467 |
Dermatologic involvement | 163 | 0.089 | 0.627 |
Peak absolute Eosinophil count | 153 | 0.104 | 0.627 |
Neurologic involvement | 164 | 0.189 | 0.871 |
T-cell receptor rearrangement | 161 | 0.297 | 0.918 |
IgE | 159 | 0.461 | 0.982 |
Pulmonary involvement | 164 | 0.462 | 0.982 |
Sinus involvement | 160 | 0.472 | 0.982 |
Erythrocyte sedimentation rate | 88 | 0.59 | 0.982 |
Pulmonary function testing | 94 | 0.666 | 0.982 |
Gastrointestinal involvement | 163 | 0.685 | 0.982 |
Serum tryptase | 152 | 0.974 | 0.982 |
Generalized estimating equations Score method, two-sided;
Permutation method adjusted for multiple comparisons; two-sided. HES-hypereosinophilic syndrome; LDH-lactose dehydrogenase,